JP2021509902A5 - - Google Patents
Info
- Publication number
- JP2021509902A5 JP2021509902A5 JP2020537217A JP2020537217A JP2021509902A5 JP 2021509902 A5 JP2021509902 A5 JP 2021509902A5 JP 2020537217 A JP2020537217 A JP 2020537217A JP 2020537217 A JP2020537217 A JP 2020537217A JP 2021509902 A5 JP2021509902 A5 JP 2021509902A5
- Authority
- JP
- Japan
- Prior art keywords
- copper
- composition
- composition according
- containing agent
- ophthalmic
- Prior art date
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023123138A JP7655988B2 (ja) | 2018-01-05 | 2023-07-28 | 近視進行の治療 |
| JP2025046160A JP2025111434A (ja) | 2018-01-05 | 2025-03-21 | 近視進行の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862614230P | 2018-01-05 | 2018-01-05 | |
| US62/614,230 | 2018-01-05 | ||
| PCT/US2019/012501 WO2019136358A1 (en) | 2018-01-05 | 2019-01-07 | Treatment of myopic progression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023123138A Division JP7655988B2 (ja) | 2018-01-05 | 2023-07-28 | 近視進行の治療 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021509902A JP2021509902A (ja) | 2021-04-08 |
| JP2021509902A5 true JP2021509902A5 (https=) | 2022-01-18 |
| JPWO2019136358A5 JPWO2019136358A5 (https=) | 2022-01-18 |
| JP7324208B2 JP7324208B2 (ja) | 2023-08-09 |
Family
ID=67143996
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020537217A Active JP7324208B2 (ja) | 2018-01-05 | 2019-01-07 | 近視進行の治療 |
| JP2023123138A Active JP7655988B2 (ja) | 2018-01-05 | 2023-07-28 | 近視進行の治療 |
| JP2025046160A Pending JP2025111434A (ja) | 2018-01-05 | 2025-03-21 | 近視進行の治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023123138A Active JP7655988B2 (ja) | 2018-01-05 | 2023-07-28 | 近視進行の治療 |
| JP2025046160A Pending JP2025111434A (ja) | 2018-01-05 | 2025-03-21 | 近視進行の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11524032B2 (https=) |
| EP (1) | EP3735209A4 (https=) |
| JP (3) | JP7324208B2 (https=) |
| KR (2) | KR20250109788A (https=) |
| CN (1) | CN112105320A (https=) |
| AU (2) | AU2019205774B2 (https=) |
| CA (1) | CA3087622A1 (https=) |
| WO (1) | WO2019136358A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11065275B2 (en) * | 2016-03-08 | 2021-07-20 | University Of Utah Research Foundation | Cross-linking agents and associated methods |
| KR20250109788A (ko) * | 2018-01-05 | 2025-07-17 | 유니버시티 오브 유타 리서치 파운데이션 | 근시 진행의 치료 |
| CA3146848A1 (en) * | 2019-07-11 | 2021-01-14 | University Of Utah Research Foundation | Multi-agent ocular formulations and treatment methods |
| TW202245810A (zh) * | 2021-02-01 | 2022-12-01 | 美商艾維娜傳送系統公司 | 散光之治療 |
| TW202302121A (zh) * | 2021-02-11 | 2023-01-16 | 猶他大學研究基金會 | 近視之治療 |
| CN115282349A (zh) * | 2022-07-05 | 2022-11-04 | 复旦大学附属眼耳鼻喉科医院 | 一种有利于改善孟加拉玫瑰红-绿光角膜胶原交联技术中cct降低的角膜交联试剂 |
| CN115386105B (zh) * | 2022-08-26 | 2024-03-22 | 昆明理工大学 | 多重酶活性纳米酶荧光水凝胶的制备方法及应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3416530A (en) | 1966-03-02 | 1968-12-17 | Richard A. Ness | Eyeball medication dispensing tablet |
| DE68913995T2 (de) | 1989-09-27 | 1994-08-25 | Mo Ni Skij I Glaznych Boleznej | Zusammensetzung zur behandlung progressiver myopie. |
| EP1159941A3 (en) * | 1991-10-15 | 2003-09-17 | Ista Pharmaceuticals, Inc. | Formulations for use in enzyme-orthokeratology |
| CN1047523C (zh) * | 1993-11-23 | 1999-12-22 | 华中理工大学 | 一种防治近视的滴眼液 |
| AU7488898A (en) | 1997-05-16 | 1998-12-08 | Corrective Vision, Inc. | Improved contact lens |
| BR9908692A (pt) * | 1998-03-09 | 2001-12-04 | Ista Pharmaceuticals Inc | Uso de agentes de enrijecimento corneal emortocerotologia enzimática |
| US6231889B1 (en) * | 1998-09-21 | 2001-05-15 | Chronorx, Llc | Unit dosage forms for the treatment of herpes simplex |
| CA2443244A1 (en) * | 2001-04-13 | 2002-10-24 | Incyte Genomics, Inc. | Enzymes |
| IL158904A0 (en) | 2001-05-25 | 2004-05-12 | Valley Forge Pharmaceuticals | Pirenzepine ophthalmic gel |
| NZ540885A (en) * | 2002-12-20 | 2009-02-28 | Chakshu Res Inc | Ophthalmic formulation for the prevention and treatment of ocular conditions |
| CN1518981A (zh) * | 2003-07-23 | 2004-08-11 | 复旦大学附属眼耳鼻喉科医院 | 一种治疗近视的外用滴眼制剂 |
| MXPA03011987A (es) * | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal. |
| WO2006055526A2 (en) | 2004-11-16 | 2006-05-26 | Nu-Tein Co., Inc. | Compositions useful to treat ocular neovascular diseases and macular degeneration |
| US20060276777A1 (en) * | 2005-04-08 | 2006-12-07 | Coroneo Minas T | Corneal shaping |
| US20080014278A1 (en) | 2006-06-30 | 2008-01-17 | Nucryst Pharmaceuticals | Metal-containing formulations and methods of use |
| WO2012161655A1 (en) | 2011-05-23 | 2012-11-29 | Singapore Health Services Pte Ltd | Composition and/or method for reducing and/or preventing myopia progression comprising atropine |
| US20140343480A1 (en) * | 2013-05-19 | 2014-11-20 | Avedro, Inc. | Systems, methods, and compositions for cross-linking |
| RU2635185C2 (ru) * | 2013-12-17 | 2017-11-09 | Иван Дмитриевич Захаров | Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости |
| WO2015155117A1 (en) * | 2014-04-09 | 2015-10-15 | Universität Leipzig | A device for a medical treatment of a sclera |
| US9421199B2 (en) | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
| CN107530324A (zh) * | 2015-04-09 | 2018-01-02 | 雷伯瑞特里巴达西公司 | 用于眼科用途的吡咯烷酮羧酸（pca） |
| US10010502B2 (en) | 2015-05-19 | 2018-07-03 | Amorphex Therapeutics Llc | Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation |
| US11065275B2 (en) | 2016-03-08 | 2021-07-20 | University Of Utah Research Foundation | Cross-linking agents and associated methods |
| AU2018371787A1 (en) | 2017-11-21 | 2020-11-05 | Sydnexis, Inc. | Ophthalmic composition and delivery device thereof |
| KR20250109788A (ko) * | 2018-01-05 | 2025-07-17 | 유니버시티 오브 유타 리서치 파운데이션 | 근시 진행의 치료 |
| CA3146848A1 (en) * | 2019-07-11 | 2021-01-14 | University Of Utah Research Foundation | Multi-agent ocular formulations and treatment methods |
| TW202245810A (zh) * | 2021-02-01 | 2022-12-01 | 美商艾維娜傳送系統公司 | 散光之治療 |
| TW202302121A (zh) * | 2021-02-11 | 2023-01-16 | 猶他大學研究基金會 | 近視之治療 |
-
2019
- 2019-01-07 KR KR1020257022145A patent/KR20250109788A/ko active Pending
- 2019-01-07 WO PCT/US2019/012501 patent/WO2019136358A1/en not_active Ceased
- 2019-01-07 AU AU2019205774A patent/AU2019205774B2/en active Active
- 2019-01-07 CN CN201980014086.4A patent/CN112105320A/zh active Pending
- 2019-01-07 US US16/960,077 patent/US11524032B2/en active Active
- 2019-01-07 KR KR1020207022632A patent/KR102831250B1/ko active Active
- 2019-01-07 JP JP2020537217A patent/JP7324208B2/ja active Active
- 2019-01-07 EP EP19735793.2A patent/EP3735209A4/en active Pending
- 2019-01-07 CA CA3087622A patent/CA3087622A1/en active Pending
-
2022
- 2022-12-13 US US18/080,466 patent/US12544400B2/en active Active
-
2023
- 2023-07-28 JP JP2023123138A patent/JP7655988B2/ja active Active
-
2024
- 2024-12-06 AU AU2024278182A patent/AU2024278182A1/en active Pending
-
2025
- 2025-03-21 JP JP2025046160A patent/JP2025111434A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021509902A5 (https=) | ||
| JP2019511493A5 (https=) | ||
| US12544400B2 (en) | Treatment of myopic progression | |
| JP2019532931A (ja) | 眼瞼炎の治療に使用するための医薬組成物 | |
| WO2010023705A1 (en) | Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders | |
| KR101820184B1 (ko) | 방부제가 없는 비마토프로스트 및 티몰롤 용액 | |
| CA3010279A1 (en) | Compositions for the treatment of presbyopia | |
| JP2019508472A (ja) | 老視の処置のための組成物及び方法 | |
| AU2016320905B2 (en) | Compositions and methods for prevention and treatment of corneal haze and scarring | |
| AU2026201640A1 (en) | Multi-agent ocular formulations and treatment methods | |
| JPWO2019136358A5 (https=) | ||
| CN110496215A (zh) | 一种治疗老视的水性滴眼液及其制备方法 | |
| EP2598117A2 (en) | Preservative free bimatoprost solutions | |
| JP2021534217A5 (https=) | ||
| JP2024504202A (ja) | 乱視の治療 | |
| WO2014138018A1 (en) | Preservative free bimatoprost and timolol solutions | |
| RU2019118904A (ru) | Распределение в глазу и фармакокинетика композиций лифитеграста | |
| MX2021006642A (es) | Compuestos y composiciones para tratamientos oculares. | |
| EP4106751A1 (en) | Alpha-2-adrenergic receptor agonists for reducing redness and increasing whiteness in eyes and other ophthalmic purposes | |
| JPWO2021007578A5 (https=) | ||
| JP2024508706A (ja) | 近視の治療 | |
| TW202317132A (zh) | 眼用組合物及/或用於老花眼、瞳孔放大及/或眼部不適管理之方法 | |
| JPWO2022174094A5 (https=) | ||
| JPWO2020041340A5 (https=) | ||
| US20250127760A1 (en) | Composition and use thereof in preparation of medicament for treating presbyopia |